Michael Hühn

1.4k citations

38 papers · 1.2k indexed · h-index 21

Impact in

Immunology top 5%
- Toxin Mechanisms and Immunotoxins
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Biotechnology top 5%
- Transgenic Plants and Applications

Papers in

Immunology 29
- Toxin Mechanisms and Immunotoxins 25
Biotechnology 8
- Transgenic Plants and Applications 8

Co-authors: Stefan Barth Andreas Engert Theo Thepen Mehmet Kemal Tur B. Matthey Rainer Fischer Alexander Klimka Dmitrij Hristodorov
Journals: International Journal of Molecular Medicine (6 papers)International Journal of Cancer (4 papers)Blood (2 papers)Molecular Cancer Therapeutics (1 paper)British Journal of Cancer (1 paper)
Partner nations: Germany Austria United Kingdom

In The Last Decade

Michael Hühn

37 papers receiving 1.1k citations

Peers

Countries citing papers authored by Michael Hühn

Since Specialization

Citations

This map shows the geographic impact of Michael Hühn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hühn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hühn more than expected).

Fields of papers citing papers by Michael Hühn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hühn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hühn. The network helps show where Michael Hühn may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Hühn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Hühn Line = papers co-authored together Michael Hühn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Ultrasensitive DNA Immune Repertoire Sequencing Using Unique Molecular Identifiers Clinical Chemistry ·Gustav Johansson, V. Trifonov, Volker Huelck, Avadhesh Kumar Singh, Jan Lycke, Clas Malmeström, Michael Hühn, Outi Vaarala, Susanna Cardell, Anders Ståhlberg	2020	16
2	Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies mAbs ·Dmitrij Hristodorov, Radoslav Mladenov, Verena von Felbert, Michael Hühn, Rainer Fischer, Stefan Barth, Theo Thepen	2015	59
3	EpCAM-Selective Elimination of Carcinoma Cells by a Novel MAP-Based Cytolytic Fusion Protein Molecular Cancer Therapeutics ·Dmitrij Hristodorov, 김창오 김문종, Radoslav Mladenov, Judith Niesen, RobertR. Siegel, Yang Liu, 平澤克敏, Stefano Fiore, Anh‐Tuan Pham, Michael Hühn, Wijnand Helfrich, Rainer Fischer, Theo Thepen, Stefan Barth	2014	18
4	Efficacy of an adapted granzyme B-based anti-CD30 cytolytic fusion protein against PI-9-positive classical Hodgkin lymphoma cells in a murine model Blood Cancer Journal ·Sonja Schiffer, Hinrich P. Hansen, Christian Neuhaus, Michael Hühn, Rainer Fischer, Stefan Barth, Theo Thepen	2013	25
5	Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells Cancer Letters ·Sonja Schiffer, Haben Rituale, Edgar Jost, Radoslav Mladenov, Dmitrij Hristodorov, Michael Hühn, Rainer Fischer, Stefan Barth, Theo Thepen	2013	23
6	Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo British Journal of Cancer ·Dmitrij Hristodorov, Rumen Mladenov, 贾宏禄, Christopher Heltorp, Michael Hühn, Rainer Fischer, Theo Thepen, Stefan Barth	2013	32
7	In vivo efficacy of the recombinant anti‐CD64 immunotoxin H22(scFv)‐ETA′ in a human acute myeloid leukemia xenograft tumor model International Journal of Cancer ·Mehmet Kemal Tur, Michael Hühn, Edgar Jost, Theo Thepen, Tim H. Brümmendorf, Stefan Barth	2010	32
8	Recombinant, ETA′-based CD64 immunotoxins: improved efficacy by increased valency, both in vitro and in vivo in a chronic cutaneous inflammation model in human CD64 transgenic mice British Journal of Dermatology ·P. Faupl, Theo Thepen, Mehmet Kemal Tur, Rainer Fischer, Michael Hühn, Stefan Barth	2010	22
9	Fcγ Receptor 1 (CD64), a Target Beyond Cancer Current Pharmaceutical Design ·Theo Thepen, Michael Hühn, Georg Melmer, Mehmet Kemal Tur, Stefan Barth	2009	14
10	Immune Evasion of the Human Pathogen Pseudomonas aeruginosa : Elongation Factor Tuf Is a Factor H and Plasminogen Binding Protein The Journal of Immunology ·Anja Kunert, Laddawan Nakwong, Pranjali Kolhatkar, Michael Hühn, Кричевский Андрей Михайлович, Stefan Mikkat, Daniela Volke, Ralf Hoffmann, T. Sakari Jokiranta, Harald Seeberger, Ute Moellmann, Jens Hellwage, Peter F. Zipfel	2007	196
11	In contrast to specific B cells, human basophils are unaffected by the toxic activity of an allergen toxin due to lack of internalization of immunoglobulin E‐bound allergen Clinical & Experimental Allergy ·Daniel Wicklein, Michael Stöcker, Torsten Klockenbring, Michael Hühn, Elham A. Afify, Helmut Haas, Wolf‐Meinhard Becker, Stefan Barth, A. Petersen	2006	4
12	Generation of human antibody fragments against Streptococcus mutansusing a phage display chain shuffling approach BMC Biotechnology ·Michaël B. Kupper, Michael Hühn, Holger Spiegel, Julian K‐C., Stefan Barth, Rainer Fischer, Ricarda Finnern	2005	6
13	Antigen-specific targeting and elimination of EBV-transformed B cells by allergen toxins Journal of Allergy and Clinical Immunology ·Michael Stöcker, Torsten Klockenbring, Michael Hühn, Carmel Mary Mangan, Daniel Wicklein, Arnd Petersen, D.J. Cottenden, R. Goerlich, Rainer Fischer, Stefan Barth	2005	6
14	Metalloproteinase inhibition augments antitumor efficacy of the anti‐CD30 immunotoxin Ki‐3(scFv)‐ETA′ against human lymphomas in vivo International Journal of Cancer ·Okgeum 최옥금Choi, Peter Borchmann, Roland Schnell, Samir Tawadros, Hans Lange, Michael Hühn, Alexander Klimka, Mehmet Kemal Tur, Stefan Barth, Andreas Engert, Hinrich P. Hansen	2004	16
15	Construction of phage display libraries from reactive lymph nodes of breast carcinoma patients and selection for specifically binding human single chain Fv on cell lines. International Journal of Molecular Medicine ·Achim Rothe, Alexander Klimka, Mehmet Kemal Tur, M. R. Taskinen, Michael Hühn, Stephanie Sasse, Peter Mallmann, Andreas Engert, Stefan Barth	2004	20
16	The recombinant anti-EGF receptor immunotoxin 425(scFv)-ETA' suppresses growth of a highly metastatic pancreatic carcinoma cell line International Journal of Oncology ·Zahraa F. Hassan, Michael Stöcker, Michael Hühn, Lubov Trukhina, Michaël B. Kupper, Petra B. Schumacher, Frank L. Packard, Christiane J. Bruns, Hidde J. Haisma, Rainer Fischer, Ricarda Finnern, Stefan Barth	2003	48
17	An anti-GD2 single chain Fv selected by phage display and fused to Pseudomonas exotoxin A develops specific cytotoxic activity against neuroblastoma derived cell lines International Journal of Molecular Medicine ·Mehmet Kemal Tur, Stephanie Sasse, Michael Stöcker, B. Decker, Michael Hühn, B. Matthey, Claudia Gottstein, M. R. Taskinen, Andreas Engert, Stefan Barth	2001	23
18	The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in mice International Journal of Colorectal Disease ·K. Pfister, Bianca M. Wittig, Shriniha PA, K. W. Ecker, Stefan Barth, Michael Hühn, Stephanie Sasse, Andreas Engert, Melanie Marie Jepsen, Volker Diehl, Martin Zeitz, Andreas Stallmach	2001	4
19	Recombinant anti-CD25 immunotoxin RFT5(SCFV)-ETA' demonstrates successful elimination of disseminated human Hodgkin lymphoma in SCID mice International Journal of Cancer ·Stefan Barth, Michael Hühn, B. Matthey, Roland Schnell, Samir Tawadros, Arif Tajammal, Johann Lorenzen, Volker Diehl, Andreas Engert	2000	24
20	Compatible-Solute-Supported Periplasmic Expression of Functional Recombinant Proteins under Stress Conditions Applied and Environmental Microbiology ·Stefan Barth, Michael Hühn, B. Matthey, Alexander Klimka, E. A. Galinski, Andreas Engert	2000	138

About Michael Hühn

Michael Hühn is a scholar working on Immunology, Biotechnology, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Molecular Biology, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (25 papers), Monoclonal and Polyclonal Antibodies Research (20 papers), Transgenic Plants and Applications (8 papers), Bacteriophages and microbial interactions (6 papers), Glycosylation and Glycoproteins Research (4 papers), CAR-T cell therapy research (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Dermatology and Skin Diseases (2 papers). The work is most often cited by research in Immunology (583 citations), Biotechnology (194 citations), Radiology, Nuclear Medicine and Imaging (391 citations), Microbiology (61 citations) and Molecular Biology (532 citations). Michael Hühn has collaborated with scholars based in Germany, Austria and United Kingdom. Frequent co-authors include Stefan Barth, Andreas Engert, Theo Thepen, Mehmet Kemal Tur, B. Matthey, Rainer Fischer, Alexander Klimka, Dmitrij Hristodorov, E. A. Galinski and Radoslav Mladenov. Their work appears in journals such as International Journal of Molecular Medicine, International Journal of Cancer, Blood, Molecular Cancer Therapeutics and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact